Research On The Supervision Of Prescription Drug Circulation Links

Health is the aspiration and pursuit of the broad masses of people,and safeguarding people’s health is an important reflection of the nature and purpose of our Party.After the founding of New China,the Party and the government vigorously developed the supervision and management of drug quality in the face of the dilapidated drug administration in the old China.After decades of efforts,China has developed into a modern scale pharmaceutical industry,formed a modern level of pharmaceutical management,and the people’s safety in drug use has been greatly improved.The Fifth Plenary Session of the 19 th CPC Central Committee put forward the major task of "comprehensively promoting the construction of a healthy China".On the basis of a profound understanding of this spiritual essence,it is inevitable that we should pay attention to the supervision of prescription drugs with high risk.Based on the theoretical basis of government regulation and campaign-based governance,this paper puts forward the research content of the supervision of prescription drugs circulation link by means of literature review,comparative study,investigation and other research methods,and by sorting out and summarizing the published statements of relevant contents at home and abroad.This paper firstly sorts out the research on the regulation of prescription drugs in China,and focuses on the means used in the regulation of prescription drugs in the United States,Japan and the European Union,and further elaborates the basic principles of government regulation in the circulation of prescription drugs.Then,this paper combined with the results of the special rectification activities and evaluation activities of Heze’s prescription drug circulation in 2019 to analyze the current situation of the regulation of prescription drug circulation in China.Then,this paper analyzes the regulatory situation of prescription drugs in foreign developed countries,and summarizes the effective experience of its regulatory.In the end,this paper from the government,enterprises,society three levels,to strengthen the prescription drug circulation supervision suggestions.Based on the process of drug regulatory reform in China,summarized the main problems existing in the current regulation of prescription drugs circulation link,and analyzed the reasons from the regulatory subjects,operators,licensed pharmacists,the role of industry associations,the public and other aspects.In this paper,based on the type of governance theory,explore a new mode of routinization,modernization and specialization management,from the government,enterprises and society three aspects put forward to further improve the effective supervision of prescription drugs circulation of countermeasures,first of all,the government departments to perfect the laws and regulations,strengthen the supervision of team construction,innovation means to strengthen supervision main body responsibility,enterprises should enhance the integrity of self-discipline,standardize management,attaches great importance to the licensed pharmacists to carry out the market main body responsibility,social level to build industry association and the news media,the public and other diversified social supervision system.In the new era,the main contradiction in Chinese society has changed,and people’s expectations for a better life have become increasingly strong.It is an inevitable requirement to do a good job in regulating the circulation of prescription drugs to ensure people’s health.